Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations

BACKGROUND: Co-use of stimulants and opioids is rapidly increasing. Randomized clinical trials (RCTs) have established the efficacy of medications for opioid use disorder (MOUD), but stimulant use may decrease the likelihood of initiating MOUD treatment. Furthermore, trial participants may not repre...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, R. R., Foot, C., Arah, O. A., Humphreys, K., Rudolph, K. E., Luo, S. X., Tsui, J. I., Levander, X. A., Korthuis, P. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930351/
https://www.ncbi.nlm.nih.gov/pubmed/36788634
http://dx.doi.org/10.1186/s13722-023-00364-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930351/
https://www.ncbi.nlm.nih.gov/pubmed/36788634
http://dx.doi.org/10.1186/s13722-023-00364-3

Ejemplares similares